4.0 Article

Access to community pharmacies: A nationwide geographic information systems cross-sectional analysis

期刊

出版社

ELSEVIER
DOI: 10.1016/j.japh.2022.07.003

关键词

-

向作者/读者索取更多资源

The accessibility of community pharmacies in the United States was quantified, and it was found that chain pharmacies dominate in urban areas while regional franchises and independent pharmacies play a key role in providing access in rural areas. The majority of the U.S. population lives within a 10-mile radius of a community pharmacy.
Background: Pharmacy accessibility is key for the emerging role of community pharmacists as providers of patient-centered, medication management services in addition to traditional dispensing roles. Objective: To quantify population access to community pharmacies across the United States. Methods: We obtained addresses for pharmacy locations in the United States from the National Council for Prescription Drug Programs and geocoded each. For a 1% sample of a U.S. synthetic population, we calculated the driving distance to the closest pharmacy using ArcGIS. We estimated the proportion of population living within 1, 2, 5, and 10 miles of a community pharmacy. We quantified the role of chain vs regional franchises or independently owned pharmacies in providing access across degrees of urbanicity. Results: We identified 61,715 pharmacies, including 37,954 (61.5%) chains, 23,521 (38.1%) regional franchises or independently owned pharmacies, and 240 (0.4%) government pharmacies. In large metropolitan areas, 62.8% of the pharmacies were chains; however, in rural areas, 76.5% of pharmacies were franchises or independent pharmacies. Across the overall U.S. population, 48.1% lived within 1 mile of any pharmacy, 73.1% within 2 miles, 88.9% within 5 miles, and 96.5% within 10 miles. Across the United States, 8.3% of counties had at least 50% of residents with a distance greater than 10 miles. These low-access counties were concentrated in Alaska, South Dakota, North Dakota, and Montana. Conclusions: Community pharmacies may serve as accessible locations for patient-centered, medication management services that enhance the health and wellness of communities. Although chain pharmacies represent the majority of pharmacy locations across the country, access to community pharmacies in rural areas predominantly relies on regional franchises and independently owned pharmacies. (c) 2022 American Pharmacists Association (R). Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.0
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Endocrinology & Metabolism

Changes in racial and ethnic disparities in glucose-lowering drug utilization and glycated haemoglobin A1c in US adults with diabetes: 2005-2018

Piaopiao Li, Ping Zhang, Dawei Guan, Jingchuan Guo, Yongkang Zhang, Meda E. Pavkov, Kai McKeever Bullard, Hui Shao

Summary: From 2005 to 2018, racial and ethnic disparities persisted in newer glucose-lowering drugs (GLD) use and quality of care in glucose management among US adults with diabetes. Non-Hispanic black, Hispanic, and other race/ethnicity groups had lower rates of using newer GLDs, lower non-insulin GLD adherence, higher glycated haemoglobin A1c, and similar insulin adherence compared to non-Hispanic white adults. Socioeconomic and health status were identified as the main contributors to these disparities.

DIABETES OBESITY & METABOLISM (2023)

Article Medicine, General & Internal

Effects of the July 2018 worldwide valsartan recall and shortage on global trends in antihypertensive medication use: a time-series analysis in 83 countries

Yuna Choi, Araniy Santhireswaran, Cherry Chu, Katie J. Suda, Inma Hernandez, Jared W. Magnani, Mina Tadrous

Summary: This study examines the effects of the global valsartan recall and shortage in July 2018 on antihypertensive medication use in 83 countries. The results show a significant decrease in global valsartan utilization, while purchases of other ARBs and ACEIs increased. The opposing trends in developed and developing countries raise concerns about the distribution of contaminated medications.

BMJ OPEN (2023)

Review Cardiac & Cardiovascular Systems

Transforming Atrial Fibrillation Research to Integrate Social Determinants of Health A National Heart, Lung, and Blood Institute Workshop Report

Emelia J. Benjamin, Kevin L. Thomas, Alan S. Go, Patrice Desvigne-Nickens, Christine M. Albert, Alvaro Alonso, Alanna M. Chamberlain, Utibe R. Essien, Inmaculada Hernandez, Mellanie True Hills, Kiarri N. Kershaw, Phillip D. Levy, Jared W. Magnani, Daniel D. Matlock, Emily C. O'Brien, Carlos J. Rodriguez, Andrea M. Russo, Elsayed Z. Soliman, Lawton S. Cooper, Sana M. Al-Khatib

Summary: The contributions of social determinants of health to atrial fibrillation (AF) have received little attention. Social determinants of health affect access to care and management decisions for AF, increasing the likelihood of adverse outcomes among individuals who experience systemic disadvantages. Research is needed to eliminate the substantive inequities in health care delivery and outcomes in AF.

JAMA CARDIOLOGY (2023)

Article Medicine, General & Internal

Association of New Use of Antihypertensives That Stimulate vs Inhibit Type 2 and 4 Angiotensin II Receptors With Dementia Among Medicare Beneficiaries

Zachary A. Marcum, Nico Gabriel, Adam P. Bress, Inmaculada Hernandez

Summary: The use of antihypertensive medications that stimulate type 2 and 4 angiotensin II receptors is associated with a lower risk of dementia.

JAMA NETWORK OPEN (2023)

Article Multidisciplinary Sciences

Indications of food insecurity in the content of telephone calls to a community referral system

Nasser A. Sharareh, Ching-Yu A. Wang, Andrea S. A. Wallace, Jorie A. Butler

Summary: This study analyzed the content of phone calls to the 211 community referral system regarding food-related issues, and explored the indications of food insecurity during these calls. The results revealed the complex social environment, lack of knowledge about available food resources, and indications of food insecurity in these calls. Therefore, these calls can be used as a proxy measure for food insecurity. Interventions should be designed to increase awareness about available resources and address the co-existing social needs with food insecurity.

PLOS ONE (2023)

Article Cardiac & Cardiovascular Systems

Ethnic Variations in Cardiovascular and Renal Outcomes From Newer Glucose-Lowering Drugs: A Meta-Analysis of Randomized Outcome Trials

Huilin Tang, Weihan Chen, Jiang Bian, LaToya J. J. O'Neal, Daniel T. T. Lackland, Desmond A. A. Schatz, Jingchuan Guo

Summary: Hispanic populations have a higher risk of developing diabetes and related diseases compared to non-Hispanic White populations. However, there is limited evidence regarding the generalizability of the cardiovascular and renal benefits of sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists to Hispanic populations.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2023)

Article Public, Environmental & Occupational Health

Racial disparities in access to health care infrastructure across US counties: A geographic information systems analysis

Jingchuan Guo, Sean Dickson, Lucas A. Berenbrok, Shangbin Tang, Utibe R. Essien, Inmaculada Hernandez

Summary: Using ArcGIS Network Analyst and a national transportation dataset, we calculated the driving distance to the closest health care facility for a representative sample of the U.S. population and found that Black residents have a longer driving distance than White residents. There were significant geographic variations in racial disparities in access to health care facilities, with concentrated disparities in the Southeast and a concentration of overall population >5 miles to the closest facility in the Midwest. This geographic variation highlights the importance of using spatially explicit data in designing equitable health care facility establishments.

FRONTIERS IN PUBLIC HEALTH (2023)

Article Medicine, General & Internal

Evaluation of Out-of-Pocket Costs and Treatment Intensification With an SGLT2 Inhibitor or GLP-1 RA in Patients With Type 2 Diabetes and Cardiovascular Disease

Jing Luo, Robert Feldman, Katherine Callaway Kim, Scott Rothenberger, Mary Korytkowski, Inmaculada Hernandez, Walid F. Gellad

Summary: This retrospective cohort study aimed to assess the association between high out-of-pocket costs and the initiation of SGLT2 inhibitors or GLP-1 receptor agonists in adults with type 2 diabetes and established cardiovascular disease. The study found that patients with the highest out-of-pocket costs were 13% less likely to initiate a GLP-1 RA and 20% less likely to initiate an SGLT2 inhibitor compared to those with the lowest out-of-pocket costs.

JAMA NETWORK OPEN (2023)

Article Medicine, General & Internal

Assessment of Commercial and Mandatory Discounts in the Gross-to-Net Bubble for the Top Insulin Products From 2012 to 2019

Sean R. Dickson, Nico Gabriel, Walid F. Gellad, Inmaculada Hernandez

Summary: Insulin list prices have increased since 2010, but net prices have declined due to manufacturer discounts, resulting in a growing gross-to-net bubble. It is unclear to what extent this bubble is due to voluntary commercial discounts or mandatory discounts under various healthcare programs. This study aimed to decompose the gross-to-net bubble of leading insulin products into different discount types.

JAMA NETWORK OPEN (2023)

Article Endocrinology & Metabolism

Incremental burden on health-related quality of life, health service utilization and direct medical expenditures associated with cognitive impairment among non-institutionalized people with diabetes aged 65 years and older

Dawei Guan, Motomori O. Lewis, Piaopiao Li, Yichen Zhang, Ping Zhang, Shichao Tang, Joshua Brown, Jingchuan Guo, Yongkang Zhang, Hui Shao

Summary: This study quantified the incremental burden of cognitive impairment (CI) on health and economics among non-institutionalized individuals aged 65 and above with diabetes in the United States. The findings showed that CI was associated with worse health-related quality of life, higher healthcare service utilization and expenditures. The results can be used to monitor the burden of CI in older individuals with diabetes.

DIABETES OBESITY & METABOLISM (2023)

Article Health Care Sciences & Services

Associations between food insecurity and other social risk factors among US adults

Nasser Sharareh, Taiwo P. Adesoba, Andrea S. Wallace, Sara Bybee, Lindsey N. Potter, Hilary Seligman, Fernando A. Wilson

Summary: Food insecurity often co-exists with other social risk factors. The association between food insecurity and other social risk factors across different income levels and before and during the COVID-19 pandemic is unknown, hindering the ability to design effective interventions.

JOURNAL OF GENERAL INTERNAL MEDICINE (2023)

Letter Medicine, General & Internal

Association Between Redlining and Spatial Access to Pharmacies

Giovanni Appolon, Shangbin Tang, Nico Gabriel, Jasmine Morales, Lucas A. Berenbrok, Jingchuan Guo, Inmaculada Hernandez

JAMA NETWORK OPEN (2023)

Letter Medicine, General & Internal

Contextualizing the Price of Biosimilar Adalimumab Based on Historical Rebates for the Original Formulation of Branded Adalimumab

Sean R. Dickson, Nico Gabriel, Inmaculada Hernandez

Summary: This study examines the recent list and net prices of Humira with rebates, comparing them with the announced prices of interchangeable biosimilar formulations of Humira.

JAMA NETWORK OPEN (2023)

Article Health Care Sciences & Services

Estimated discounts generated by Medicare drug negotiation in 2026

Inmaculada Hernandez, Nico Gabriel, S. Dickson

Summary: This study identifies the maximum negotiated price for the 10 drugs expected to be negotiated by Medicare in 2026. The results show that minimum discounts will only apply to 4 of the 10 drugs likely subject to negotiation, and achieving the projected savings will require negotiated prices to fall below the established ceiling.

JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY (2023)

Article Health Care Sciences & Services

Drugs likely subject to Medicare negotiation, 2026-2028

Sean Dickson, Inmaculada Hernandez

Summary: Based on the criteria and spending data, it is estimated that Medicare will negotiate the prices of 40 drugs in 2026-2028, including inhalers, antidiabetics, kinase inhibitors, and oral anticoagulants. This has the potential to reduce healthcare costs.

JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY (2023)

暂无数据